International Flavors & Fragrances Inc. (BIT:1IFF)
Italy
· Delayed Price · Currency is EUR 69.34
+1.12 (1.64%)
At close: May 2, 2025
Revenue by Product
Financial numbers in millions USD.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Nourish | 5,871 |
Log In |
Log In |
Log In |
Log In |
| Nourish Growth | -3.12% |
Log In |
Log In |
Log In |
Log In |
| Health & Biosciences | 2,212 |
Log In |
Log In |
Log In |
Log In |
| Health & Biosciences Growth | 6.30% |
Log In |
Log In |
Log In |
Log In |
| Scent | 2,440 |
Log In |
Log In |
Log In |
Log In |
| Scent Growth | 1.96% |
Log In |
Log In |
Log In |
Log In |
| Pharma Solutions | 961 |
Log In |
Log In |
Log In |
Log In |
| Pharma Solutions Growth | 1.69% |
Log In |
Log In |
Log In |
Log In |
Capex by Product
Financial numbers in millions USD.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Nourish Capital Expenditures | 235 |
Log In |
Log In |
Log In |
Log In |
| Nourish Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In |
| Health & Biosciences Capital Expenditures | 73 |
Log In |
Log In |
Log In |
Log In |
| Health & Biosciences Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In |
| Scent Capital Expenditures | 70 |
Log In |
Log In |
Log In |
Log In |
| Scent Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In |
| Pharma Solutions Capital Expenditures | 85 |
Log In |
Log In |
Log In |
Log In |
| Pharma Solutions Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In |
EBITDA by Product
Financial numbers in millions USD.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Nourish Adjusted Operating EBITDA | 824 |
Log In |
Log In |
Log In |
Log In |
| Nourish Adjusted Operating EBITDA Growth | 12.57% |
Log In |
Log In |
Log In |
Log In |
| Health & Biosciences Adjusted Operating EBITDA | 654 |
Log In |
Log In |
Log In |
Log In |
| Health & Biosciences Adjusted Operating EBITDA Growth | 11.22% |
Log In |
Log In |
Log In |
Log In |
| Scent Adjusted Operating EBITDA | 518 |
Log In |
Log In |
Log In |
Log In |
| Scent Adjusted Operating EBITDA Growth | 12.36% |
Log In |
Log In |
Log In |
Log In |
| Pharma Solutions Adjusted Operating EBITDA | 209 |
Log In |
Log In |
Log In |
Log In |
| Pharma Solutions Adjusted Operating EBITDA Growth | 5.03% |
Log In |
Log In |
Log In |
Log In |